Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Die Diagnose

  • Chapter
Vincent van Gogh

  • 122 Accesses

Zusammenfassung

Die behandelnden Ärzte van Goghs in Südfrankreich faßten sich in ihren Eintragungen in das Krankenregister recht kurz.1 Felix Rey, ein junger Internist, der in Arles als Assistenzarzt tätig und zu jener Zeit noch ohne Abschluß war, kümmerte sich um Vincent nach dessen erster Krise. Dr. Peyron, ein ehemaliger Militäraugenarzt, absolvierte eine zweite Laufbahn als Leiter der Anstalt von St. Rémy. Die Urteile der Nachwelt über die beiden Ärzte fallen unterschiedlich aus.

„Unsere Neurose (...) ist auch ein fatales Erbe.“

Vincent an Theo aus Arles, 4. Mai 1888

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Anmerkungen

  1. Tralbaut, M. E., 1981: Vincent van Gogh, New York, The Alpine Fine Art Collection, Ltd.

    Google Scholar 

  2. Zu diesem Standpunkt siehe Gastaut, H., 1956: La maladie de Vincent van Gogh envisagee ä la lumiere des conceptions nouvelles sur l’epilepsie psychomotrice, in: Annales Medico-Psychologiques, Bd. 1 für 1956, S. 196–238; hierin wird Dr. Aussoleil, ein Freund von Dr. Rey, als Experte auf dem Gebiet der versteckten Epilepsie genannt.

    Google Scholar 

  3. Voskuil, P. H. A., 1983: The epilepsy of Fjodor Mikhailovitch Dostoevsky (1821–1881), in Epilepsia, 24: 658–667.

    Google Scholar 

  4. Lubin, A. J., 1987: Stranger on the Earth: A Psychological Biography of Vincent van Gogh, New York, Henry Holt & Co.

    Google Scholar 

  5. Arnold, W. N., 1988: Vincent van Gogh and the thujone connection, in: fournal of the American Medical Assoäation, 260: 3042–3044.

    Google Scholar 

  6. Loftus, L. S., u. Arnold, W. N., 1991: Vincent van Gogh’s illness: acute intermittant porphyria?, in: British Medical fournal, 303: 1589–1591.

    Google Scholar 

  7. The Complete Letters of Vincent van Gogh, 2. Aufl., 1978, Boston, New York Graphic Society.

    Google Scholar 

  8. Hemphill, R. E., 1961: The illness of Vincent van Gogh, in: Proceedings of the Royal Society of Mediane, 54: 1083–1088.

    Google Scholar 

  9. Tralbaut, M. E., a.a.O., S. 177–178.

    Google Scholar 

  10. Tralbaut, M.E., a.a.O., S. 276.

    Google Scholar 

  11. van Gogh-Bonger, J., 1978: Memoirs of Vincent van Gogh, Bd. I, S. XLV-XLVI, in: The Complete Letters of Vincent van Gogh, 2. Aufl., Boston, New York Graphic Society.

    Google Scholar 

  12. Stokvis, B. J., 1889: Over twee zeldzame kleurstoffen in urine van zieken, in: Weekblad van het Nederlands Tijdschrift voor Geneeskunde, 2: 409–417.

    Google Scholar 

  13. With, T. K., 1980: A short history of porphyrins and the porphyrias, in: International fournal of Biochemistry, 11: 189–200.

    Google Scholar 

  14. Waldenström, J., 1957: The porphyrias as inborn errors of metabolism, in: American fournal of Medicine, 22: 758–773.

    Google Scholar 

  15. Tishler, P. V., Woodward, B., O’ConnorJ., Holbrook, D. A., Seidman, L. J., Hallet, M., u. Knighton, D. J., 1985: High prevalence of intermittent acute porphyria in a Psychiatric patient population, in: American fournal of Psychiatry, 124: 1430–1436.

    Google Scholar 

  16. Bonkovsky, H. L., Sinclair, P. R., Emery, S. u. Sinclair,J. F., 1980: Seizure management in acute hepatic porphyria: risks of Valproate and clonazepam, in: Neurology, 30: 588–592.

    Google Scholar 

  17. Ivers, W. M., 1951: Acute intermittent porphyria, in: fournal ofUrology, 66: 816–818.

    Google Scholar 

  18. Grossfeld, E., 1951: Acute porphyria with unusual features, in: British MedicalJournal, Bd. 1 für 1951, S. 1290–1293.

    Google Scholar 

  19. Sack, G. H.jun., 1990: Acute intermittent porphyria, in: fournal ofthe American Medical Association, 264: 1290–1293.

    Google Scholar 

  20. Kappas, A., Sassa, S., Galbraith, R. A., u. Nordman, Y., 1989: The porphyrias, S. 1305–1365, in: The Metabolie Basis of Inherited Disease, 6. Aufl., C. R. Scriver, A. L. Beaudet, W. S. Sly u. D. Valle (Hrsg.), New York, McGraw-Hill.

    Google Scholar 

  21. Laiwah, A. A. C. Y., Mactier, R., McColl, K E. L., Moore, M. R. u. Goldberg, A., 1983: Early-onset chronic renal failure as a complication of acute intermittent porphyria, in: Quarterly fournal of Mediane, 52: 92–98.

    Google Scholar 

  22. Lai, C. W., Hung, T. P., u. Lin, W. S. J., 1977: Blindness of cerebral origin in acute intermittent porphyria, in: Archives ofNeurology, 34: 210–312.

    Google Scholar 

  23. Ridley, A., 1969: The neuropathy of acute intermittent porphyria, in: The Quarterly Journal ofMedicine, 38: 307–333.

    Google Scholar 

  24. Moore, M. R., 1980: International review of drugs in acute porphyria, in: Internationaljournal ofBiochemistry, 12: 1089–1097.

    Google Scholar 

  25. Weiland, F. H., Hellman, E. S., Gaddis, E. M., Collins, A., Hunter, G. W. jun., u. Tschudy, D. R, 1964: Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria. I. The effects of diet, in: Metabolism, 13: 232–250.

    Google Scholar 

  26. Knudsen, K. B., Sparberg, M. u. Lecocq, F., 1967: Porphyria precipiotated by fasting, in: New England Journal of Mediane, 277: 350–351.

    Google Scholar 

  27. Lip, G. Y. H., McColl, K. E. L., Goldberg, A., u. Moore, M. R., 1991: Smoking and recurrent attacks of acute intermittent porphyria, in: British Medicalfournal, 302: 507.

    Google Scholar 

  28. Bickers, D. R., Miller, L., u. Kappas, A., 1975: Exacerbation of hereditäry hepatic porphyria by surreptitious ingestion of an unusual provocative agent, a mouthwash preparation, in: New England Journal of Mediane, 292: 1115–1116.

    Google Scholar 

  29. Goldberg, A. u. Rimington, C., 1962: Diseases of Porphyria Metabolism, S. 64–109, Springfield, C. C. Thomas.

    Google Scholar 

  30. Battersby, A. R., Fookes, C. J. R., Matcham, G. W. J., u. McDonald, E., 1980: Biosynthesis of the pigments of life: formation of the macrocycle, in: Nature, 285: 17–21.

    Google Scholar 

  31. Lascelles, J., 1960: The synthesios of enzymes concerned in bacteriochlorophyll formation in growing cultures of Rhodopseudomonas spheroides, in: Journal of General Microbiobgy, 23: 487–498.

    Google Scholar 

  32. Scholnick, P. L., Hammaker, L. E. u. Marver, H. S., 1969: Soluble hepatic 5-aminole-vulinic acid synthetase: end-product inhibition of the partially purified enzyme, in: Proceedings of the National Academy of Science (USA), 63: 65–70.

    Google Scholar 

  33. Tschudy, D. P., Weiland, F. H., Collins, A., u. Hunter, G. jun., 1964: The effect of carbohydrate feeding on the induction of 5-aminolevulinic acid synthetase, in: Metabolism, 13: 396–406.

    Google Scholar 

  34. Sassa, S., Bradlow, H. L., u. Kappas, A., 1979: Steroid induction of 5-aminolevulinic acid synthetase and porphyrins in liver: structure-activity studies on the permissive effects of hormones on the induction process, in: Journal of Biological Chemistry, 254: 10011–10020.

    Google Scholar 

  35. Strand, L. J., Felsher, B. F., Redeker, A. G. u. Marver, H.S., 1970: Enzymatic abnor-mality in heme biosyntheses in acute intermittent porphyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased 5-aminolevulinic acid synthetase activity, in: Proceedings of the National Academy of Science (USA), 67: 1315–1320.

    Google Scholar 

  36. Magnussen, C. R., Levine, J. B., Doherty,J. M., Cheesman,J. O., u. Tschudy, D. P., 1974: A red cell enzyme method for the diagnosis of acute intermittent porphyria, in: Blood, 44: 857–868.

    Google Scholar 

  37. Becker, D. M., u. Kramer, S., 1977: The neurological manifestations of porphyria: a review, in: Medicine, 56: 411–423.

    Google Scholar 

  38. Müller, W. E., u. Snyder, S. H., 1977: 5-aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria, in: Annais of Neurology, 2: 340–342.

    Google Scholar 

  39. Meyer, U. A., Strand, L. J., Doss, M., Rees A. C. u. Marver, H. S., 1972: Intermittent acute porphyria: demonstration of a genetic defect in porphobilinogen metabolism, in: New England Journal of Mediane, 286: 1277–1282.

    Google Scholar 

  40. Litman, D. A. u. Correia, M. A., 1985: Elevated brain tryptophan and enhanced 5-hydroxytryptamine turnover in acute hepatic heme deficiency: clinical implica-tions, in: Journal of Pharmacology and Experimental Therapeutics, 232: 337–345.

    Google Scholar 

  41. Tschudy, D. P., Valsamis, M., u. Magnussen, C. R., 1975: Acute intermittent porphyria: clinical and selected research aspects, in: Annais of Internal Medicine, 83: 851–864.

    Google Scholar 

  42. Meyer, U. A. u. Schmid, R., 1978: The porphyrias, S. 1160–1220, in: The Metabolie Basis of Inherited Disease, 4. Aufl., J.B. Stanbury, J. B. Wyngaarden u. D. S. Fredrick-son (Hrsg.), New York, McGraw Hill Book Company.

    Google Scholar 

  43. Lieber, C. S., Teschke, R., Hasumura, Y., u. Decarli, L. M., 1975: Differences in hepatic and metabolic changes after acute and chronic alcohol consumption, in: Federation Proceedings, 34: 2060–2074.

    Google Scholar 

  44. Granick, S., 1966: The induetion in vitro of the synthesis of 5-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals, in: fournal ofBiological Chemistry, 241: 1359–1375.

    Google Scholar 

  45. Mustajoki, R, u. Koskelo, R, 1976: Hereditary hepatic porphyrias in Finland, in: Acta Medica Scandinavica, 200: 171–178.

    Google Scholar 

  46. Barker, L. F. u. Estes, W. L., 1912: Family hematoporphyrinuria in association with chronic gastroduodenal dilation, peculiar fits and acute Polyneuritis: a Preliminary report, in: fournal of the American Medical Association, 59: 718–719.

    Google Scholar 

  47. Waldenström, J., 1937: Studien über Porphyrie, in: Acta Medica Scandinavica, 82 (Suppl.): 1–254.

    Google Scholar 

  48. Gates, R. R., 1946: Human Genetics, New York, Macmillan.

    Google Scholar 

  49. Wang, A.-L., Arredondo-Wega, F. X., Giampetro, P. F., Smith, M., Anderson, W. F. u. Desnick, R. J., 1981: Regional gene assignment for human porphobilinogen deami-nase and esterase-A4 to chromosome 11, in: Proceedings of the National Academy of Science (USA), 78: 5734–5738.

    Google Scholar 

  50. Mustajoki, P., u. Desnick, R. J., 1985: Genetic heterogeneity in acute intermittent porphyria: characterisation and frequency of porphobilinogen deaminase muta-tions in Finland, in: British Medical fournal, 291: 505–509.

    Google Scholar 

  51. Kappas, A., Bradlow, H. L., Bickers, D. R. u. Alvares, A. P., 1977: Induetion of a deficiency of Steroid 4–5-a-reductase activity in liver by a porphyrin gene, in: fournal of Clinical Investigation, 59: 159–169.

    Google Scholar 

  52. Becker, B., Shin, D. H., Palmberg, P. F., u. Waltman, S. R., 1976: HLA antigens and corticosteroid response, in: Science, 194: 1427–1437.

    Google Scholar 

  53. Herrick, A. L., McColl, K. E. L., Wallace, A. M., Moore, M. R. u. Goldberg, A., 1990: Elevation of hormone-binding globulins in acute intermittent porphyria, in: Clinica ChimicaActa, 187: 141–148.

    Google Scholar 

  54. Grandchamp, B., de Verneuil, H., Beaumont, C., Chretien, S., Walter, O., u. Nord-man, Y., 1987: Tissue-specific expression of porphobilinogen deaminase. Two isoen-zymes from a Single gene, in: European fournal of Biochemistry, 162: 105–110.

    Google Scholar 

  55. Grandchamp, B., Picat, C., Kauppinen, R., Mignotte, V., Peltonen. L., Mustajki, P., Romeo, P. H., Goossens, M., u. Nordman, Y., 1989: Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase, in: European fournal of Clinical Investigation, 19: 415–418.

    Google Scholar 

  56. Grandchamp, B., Picat, C., Mignotte, V., Wilson,J. H. P., Te Velde, K., Sandkuyl, L., Romeo, P. H., Goossens, M., u. Nordman, Y, 1989: Tissue-specific splicing mutation in acute intermittent porphyria, in: Proceedings of the National Academy of Science (USA), 86: 661–664.

    Google Scholar 

  57. Goldberg, A., 1985: Molecular genetics of acute intermittent porphyria, in: British MedicalJournal, 291: 499–500.

    Google Scholar 

  58. Tralbaut, M. E., a.a.O., S. 16–17.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Westwood Hills, Kansas, USA

    Wilfred Niels Arnold

Authors
  1. Wilfred Niels Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Basel AG

About this chapter

Cite this chapter

Arnold, W.N. (1993). Die Diagnose. In: Vincent van Gogh. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-6217-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-6217-2_5

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-6218-9

  • Online ISBN: 978-3-0348-6217-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation